UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Agricultural Biotechnology

Enhancing Photosynthesis: a Big Deal

The PhotoSeed Technology

Enhancing photosynthesis is a critical step to increasing crop yields. This complex 156 step biochemical process has been the subject of many studies in multiple crops. While some step wise gains have been made, the true potential for increasing photosynthesis has not been realized potentially due to the negative feedback mechanisms that exist within plants to regulate this process.

Read More

Positive Regulatory Developments for the U.S. Ag Tech Industry

2019 may prove to be propitious in terms of meaningful improvements to the regulatory strictures facing agricultural biotech and biologically based products.

In a move that will hopefully lead to positive changes in the regulatory situation facing ag biotech products, on June 11, 2019, President Trump signed an Executive Order directing the heads of the U.S. Department of Agriculture (USDA), Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) to take specific steps to streamline and improve the regulatory processes applicable to the products of agricultural biotechnology.

Read More

A global perspective on the developments in biotech regulations

The ECJ ruling on GMOs has raised pertinent issues. How will it impact on current and future research? What are the optimum routes to progressing plant research?

In light of the ruling, it was a good time to welcome experts in policy and regulatory affairs to the recent 7th Plant Genomics & Gene Editing Congress: Europe to explore these issues. We’re lucky to be able to share this presentation from the event for those that weren’t able to make it. Watch it here.

Read More

Assessment of the European Court of Justice ruling on gene editing for crop improvement

Anyone involved in the field of agriculture and biotechnology would have been unable to ignore the ECJ ruling on case C-528/16 in July 2018. The ruling confirmed that all plants obtained by any form of mutagenesis are GMOs as defined by Directive (EC) no. 2001/18 and rejected an annulment of mutagenesis exemption (Annex IB of Directive 2001/18. With significant ramifications across the industry, the ECJ stance on gene edited crops and GMOs was a major focus of the 7th Plant Genomics & Gene Editing Congress: Europe.

Read More

A novel fungal endophyte confers fitness benefits to crops

Researchers at the Polytechnic University of Madrid (UPM) in Spain, in collaboration with scientists with PlantResponse Biotech, S.L., are conducting research on a novel fungal endophyte that confers crop fitness benefits, particularly in alkaline soils.

Read More

Using pathogen genome-informed strategies to understand the molecular mechanism plant disease

A key feature of our Congresses is the opportunity given to early career researchers to present their work.

At the upcoming 7th Plant Genomics & Gene Editing Congress: EuropeEgem Ozbudak will be one of four early career researchers to be given a 15-minute platform to present their work and receive a free registration pass for both days of the conference.

He will be discussing his research project on Colletotrichum acutatum, the causative agent of anthracnose crown and fruit rot, recognized as the second most important pathogen of strawberries on the globe due to its economic impacts.

Read More

Developing Live Microbial Products with Science Driven Understanding

Günter Welz is part of the Open Innovation and Strategic Partnerships department at Bayer. He scouts for and builds relationships with external innovators in academia and business to enrich Bayer’s R&D pipeline, using various tools like the Open Innovation website and the venture capital arm.

Read More

Bridging the policy-practice divide in genome-editing for agriculture

Regulation of emerging technology such as genome editing has mainly focused on responding to the consequences of innovation. The classical regulatory model of “identification-quantification-assessment-safety management” takes a risk-oriented approach to regulation of emerging technology and focuses on constraining the practice of science based on ethics, and administrative and risk management procedures.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive